BioTelemetry (BEAT) Tops Q2 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street gains as healthcare stocks rally, oil prices fall
- Brent slips in choppy session as investors weigh attacks on ships, Saudi energy
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
- Cerebras Systems falls as TD Cowen cuts price target
- Nasdaq climbs as chip and AI-linked stocks bounce back
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
- 3M issues warrant to Amazon in $6B data center product deal
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
BioTelemetry, Inc. Reports Second Quarter 2020 Financial Results
July 30, 2020 4:05 PM EDTMALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended June 30, 2020.
Company Highlights
Recognized quarterly total revenue of $99.1 millionTotal revenue declined 11.4% year-over-year due to the impact of COVID-19 across most of our businessesReported quarterly GAAP net income of $2.3 million, or 2.3% of total revenueRealized quarterly adjusted EBITDA of $25.6 million, or 25.8% of total revenueAcquired Remote... More


